New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Anesthesia Risks SAN DIEGO (March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity
Risk of iron overload in obesity and implications in metabolic health
Efficacy of divalproex vs lithium and placebo in the treatment of mania
Elevations in circulating free fatty acids due to insulin resistance, coupled with increased intrahepatic fat, lead to impaired glucose tolerance and worsening insulin resistance, creating a vicious cycle
Finding the right tirzepatide dosage for weight loss is a process that should be guided by a professional
Serum potassium should be closely observed the first 48 hours and potassium should be administered if necessary